MedTrace Logo

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

NCT03835741 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2025-09-04

No results posted yet for this study

Summary

The aim of this study is to evaluate if automated adjustment of oxygen (with FreeO2 device) can reduce the hospital length of stay for acute exacerbation of COPD with comparison of manual oxygen titration.

Conditions

  • Oxygen Toxicity
  • COPD Exacerbation
  • Hyperoxia
  • Hypoxemia
  • Hypoxic Respiratory Failure

Interventions

DEVICE

FreeO2

an automated adjustment of oxygen during patient hospitalisation by FreeO2 device

OTHER

manual titration

a manual adjustment of oxygen during patient hospitalisation by hospital staff

Sponsors & Collaborators

  • Laval University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-17
Primary Completion
2024-07-12
Completion
2024-07-12

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835741 on ClinicalTrials.gov